# metadata.dc.description.abstract[].value
Nearly 90 years ago, Drury and Szent-Györgyi revealed that adenosine produced profound hypotension and bradycardia, and it affected kidney function in mammals [1]. Since then, the physiological role and potential therapeutic use of adenosine have been extensively explored [2,3]. Adenosine is considered a retaliatory metabolite [4], thus increasing oxygen supply and decreasing oxygen consumption.

# metadata.dc.rights[].value
cc-by (c) Ciruela Alférez, Francisco et al., 2017

# metadata.dc.source[].value
Articles publicats en revistes (Patologia i Terapèutica Experimental)